Paul A. Friedman, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 144,188 shares at $244.31 ($35.2M) on 2024-04-04, disclosed to the SEC on 2024-04-05.
Scheduled sale ($35.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $242.00 | 185 | $45K | 0.1% |
| 2 | $243.64 | 2,294 | $559K | 1.6% |
| 3 | $243.64 | 2,294 | $559K | 1.6% |
| 4 | $244.58 | 4,301 | $1.1M | 3.0% |
| 5 | $244.58 | 4,301 | $1.1M | 3.0% |
| 6 | $245.34 | 18,806 |
| $4.6M |
| 13.1% |
| 7 | $245.34 | 18,806 | $4.6M | 13.1% |
| 8 | $246.31 | 1,821 | $449K | 1.3% |
| 9 | $246.31 | 1,821 | $449K | 1.3% |
| 10 | $241.07 | 6,273 | $1.5M | 4.3% |
| 11 | $241.07 | 6,273 | $1.5M | 4.3% |
| 12 | $242.25 | 5,299 | $1.3M | 3.6% |
| 13 | $242.25 | 5,299 | $1.3M | 3.6% |
| 14 | $243.00 | 1,467 | $356K | 1.0% |
| 15 | $244.31 | 627 | $153K | 0.4% |
| 16 | $244.31 | 627 | $153K | 0.4% |
| 17 | $245.14 | 2,549 | $625K | 1.8% |
| 18 | $245.14 | 2,549 | $625K | 1.8% |
| 19 | $246.13 | 1,558 | $383K | 1.1% |
| 20 | $246.13 | 1,558 | $383K | 1.1% |
| 21 | $247.14 | 737 | $182K | 0.5% |
| 22 | $247.14 | 737 | $182K | 0.5% |
| 23 | $248.43 | 200 | $50K | 0.1% |
| 24 | $240.10 | 1,420 | $341K | 1.0% |
| 25 | $241.15 | 612 | $148K | 0.4% |
| 26 | $241.15 | 612 | $148K | 0.4% |
| 27 | $242.42 | 6,679 | $1.6M | 4.6% |
| 28 | $242.42 | 6,679 | $1.6M | 4.6% |
| 29 | $243.20 | 9,264 | $2.3M | 6.4% |
| 30 | $243.20 | 9,264 | $2.3M | 6.4% |
| 31 | $244.22 | 3,966 | $969K | 2.8% |
| 32 | $244.22 | 3,966 | $969K | 2.8% |
| 33 | $245.35 | 5,228 | $1.3M | 3.6% |
| 34 | $245.35 | 5,228 | $1.3M | 3.6% |
| 35 | $245.92 | 444 | $109K | 0.3% |
| 36 | $245.92 | 444 | $109K | 0.3% |
| Total | $243.97 avg | 144,188 | $35.2M | 100% |
| Filing → |
| MDGL | SELL | 2025-12-12 | $26.5M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $95.1M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $30.6M | — | Filing → |